BIS ETF

BIS ETF
$11.40
See how much of BIS you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
-6.37%
3 Months
-24.43%
6 Months
-38.76%
YTD
-43.17%
1 Year
-49.81%
3 Years (annualized)
-38.86%
5 Years (annualized)
-20.50%
10 Years (annualized)
-27.86%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would BIS have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
NASDAQ Biotechnology Index(^NBI)
This ETF (YTD)
-43.17%
Peer Avg (YTD)
+8.19%
vs Peers
-51.37%

BIS ETF Performance

BIS performance across multiple time periods: 1-month -6.37%, YTD -43.17%, 1-year -49.81%, 3-year -38.86%, 5-year -20.50%, 10-year -27.86%.

BIS returns trail the peer average of 8.19% YTD. With an expense ratio of 0.95%, investors should weigh costs against performance when evaluating this ETF.

BIS vs another fund shows side-by-side returns. BIS alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal Return
1 Month-6.37%
3 Months-24.43%
6 Months-38.76%
1 Year-49.81%
3 Years-38.86%
5 Years-20.50%

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized. Return figures last updated Nov 15, 2026.